Patent · US Expired

2-Aminoalkyl-thieno[2,3-d]pyrimidines

US7259168B2 · kind B2 · utility

1Cited by

4References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Rochus Jonas · Darmstadt, DE
Pierre Schelling · Mühltal, DE
Maria Christadler · Darmstadt, DE
Norbert Beier · Reinheim, DE

Key dates

Filing date	Jun 28, 2001
Grant date	Aug 21, 2007
Priority date	—
Expiry date	Apr 25, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to 2-aminomethylthieno[2,3-d]pyrimidines of the general formula (I)in which the radicals R1 to R6 have the meaning indicated in the text. The compounds show phosphodiesterase V inhibition and can be employed for the treatment of conditions of the cardiovascular system and for the treatment of potency disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.